AUTHOR=Moles Michael W. , Erdlei Henry , Menzel Lutz , Massaro Marialucia , Fiori Agnese , Bunse Mario , Schrimpf Moritz , Gerlach Kerstin , Gudipati Venugopal , Reiser John , Mathavan Ketan , Goodrich Jodie P. , Huppa Johannes B. , Krönke Jan , Valamehr Bahram , Höpken Uta E. , Rehm Armin TITLE=CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myeloma JOURNAL=Frontiers in Immunology VOLUME=15 YEAR=2024 URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1383136 DOI=10.3389/fimmu.2024.1383136 ISSN=1664-3224 ABSTRACT=
Multiple myeloma (MM) is a plasma cell disease with a preferential bone marrow (BM) tropism. Enforced expression of tissue-specific chemokine receptors has been shown to successfully guide adoptively-transferred CAR NK cells towards the malignant milieu in solid cancers, but also to BM-resident AML and MM. For redirection towards BM-associated chemokine CXCL12, we armored BCMA CAR-NK-92 as well as primary NK cells with ectopic expression of either wildtype CXCR4 or a gain-of-function mutant CXCR4R334X. Our data showed that BCMA CAR-NK-92 and -primary NK cells equipped with CXCR4 gained an improved ability to migrate towards CXCL12